DarioHealth to Participate in the Stifel 2021 Virtual Cross Sector Insight Conference

Rhea-AI Summary

DarioHealth Corp. (Nasdaq: DRIO) announced its participation in the Stifel 2021 Virtual Cross Sector Insight Conference, scheduled for June 9, 2021, at 8:00 a.m. ET. CEO Erez Raphael and President Rick Anderson will present in a virtual format. Interested attendees can access both live and archived webcasts via DarioHealth's investor website. DarioHealth is a leader in digital therapeutics, offering AI-powered solutions that help individuals manage chronic conditions effectively. The company is expanding its services across various regions and medical conditions.

NEW YORK, June 3, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Stifel 2021 Virtual Cross Sector Insight Conference.

 

 

Erez Raphael, Chief Executive Officer, and Rick Anderson, President and General manager of North America are scheduled to present in a virtual setting on Wednesday, June 9^th, 2021 at 8:00 a.m. ET. Interested parties can access the live and archived webcast at www.dariohealth.investorroom.com.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario's next-generation, AI-powered, digital therapeutic solutions support more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users' health. Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.

DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220

Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390

View original content:http://www.prnewswire.com/news-releases/dariohealth-to-participate-in-the-stifel-2021-virtual-cross-sector-insight-conference-301304910.html

SOURCE DarioHealth Corp.

FAQ

What is DarioHealth's participation in the Stifel 2021 Virtual Conference?

DarioHealth will present at the Stifel 2021 Virtual Cross Sector Insight Conference on June 9, 2021, at 8:00 a.m. ET.

Who will represent DarioHealth at the Stifel conference?

CEO Erez Raphael and President Rick Anderson are the representatives from DarioHealth for the Stifel conference.

How can I access DarioHealth's presentation at the Stifel conference?

The presentation can be accessed live and in archive format at DarioHealth's investor website: www.dariohealth.investorroom.com.

What does DarioHealth specialize in?

DarioHealth specializes in digital therapeutics, providing AI-driven solutions for managing chronic health conditions.

What is the stock symbol for DarioHealth?

DarioHealth is listed under the stock symbol DRIO on Nasdaq.